Skip to content

Impact of medium-chain triglycerides on gait performance and brain metabolic network in healthy older adults: a double-blind, randomized controlled study

GeroScience
Q1
Apr 2022
Citations: 11
Influential: 1
Interventional (Human) Studies
76

What this study found

Three months of MCT supplementation improved walking balance compared with placebo, but it did not produce clear overall cognitive benefits. The Lissajous index in the MCT arm improved from 33.9 ± 19.9 at baseline to 23.1 ± 14.4 after treatment, with an intergroup P3 = 0.009 and time-by-treatment effects P < 0.01. MCTs were also associated with suppressed glucose metabolism in the right sensorimotor cortex (FDR-corrected P = 0.046) and increased functional connectivity from the cerebellum to motor and limbic regions. Six participants (5%) reported mild gastrointestinal symptoms within 1…

Study & population
Double-blind, randomized controlled trial conducted in Japan in healthy older adults aged 65 to 80 years without dementia or major medical conditions.
Intervention
Participants in the active arm received medium-chain triglycerides (MCTs) as a yogurt-flavored jelly stick, 18 g/day total, taken before meals for 3 consecutive months.
Key limitation
The active arm was small (N = 32) and the intervention lasted only 3 months, limiting precision and long-term inference.
View sourceOpen PDF

Original abstract

No abstract is available for this paper.

Supplement AI is available on the web and as Supplement AI: Stack Optimizer on the iOS App Store. It provides evidence-based decision support, not medical advice, diagnosis, or treatment. The only official Supplement AI domain is supplementai.io; we are not affiliated with similarly named apps or services.

Select a display theme